Clinical Trials Browser

OTHER × Medulloblastoma × Eflornithine × Clear all

NCT04696029 2026-03-02

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

Phase 2 Recruiting

Medulloblastoma

NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive